Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Read More

Overview

Feature Articles

Latest Lung Cancer News and Research

Alzheimer’s protein found to drive lung cancer spread to the brain

Alzheimer’s protein found to drive lung cancer spread to the brain

AI tool matches doctors in accurately outlining lung tumors on CT scans

AI tool matches doctors in accurately outlining lung tumors on CT scans

Cannabis smoking changes your DNA, leaving epigenetic scars

Cannabis smoking changes your DNA, leaving epigenetic scars

Study maps HER2 mutations in lung cancer patients from Northeastern Brazil

Study maps HER2 mutations in lung cancer patients from Northeastern Brazil

Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412

Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412

IL-6 and CRP offer limited boost for predicting infections after lung cancer surgery

IL-6 and CRP offer limited boost for predicting infections after lung cancer surgery

Fusion genes found to be pivotal players in cancer development

Fusion genes found to be pivotal players in cancer development

New KRAS mutation discovery opens door to targeted colon cancer therapies

New KRAS mutation discovery opens door to targeted colon cancer therapies

Bispecific antibodies offer new hope for resistant NSCLC patients

Bispecific antibodies offer new hope for resistant NSCLC patients

Researchers turn a deadly fungus into potent cancer-fighting compound

Researchers turn a deadly fungus into potent cancer-fighting compound

Electromagnetic navigation bronchoscopy emerges as an effective alternative for lung nodule localization

Electromagnetic navigation bronchoscopy emerges as an effective alternative for lung nodule localization

Transfer RNA-derived small RNAs transform the landscape of liquid biopsy

Transfer RNA-derived small RNAs transform the landscape of liquid biopsy

Heart disease markers may predict future cancer risk

Heart disease markers may predict future cancer risk

Bringing microbiome science into everyday clinical care

Bringing microbiome science into everyday clinical care

STS launches mobile app for real time surgical risk assessment

STS launches mobile app for real time surgical risk assessment

Predicting deep vein thrombosis in patients with epithelial ovarian cancer using a nomogram

Predicting deep vein thrombosis in patients with epithelial ovarian cancer using a nomogram

CHAF1B drives lung squamous cell carcinoma progression by repressing SETD7

CHAF1B drives lung squamous cell carcinoma progression by repressing SETD7

Lung cells in COPD patients show higher levels of soot-like carbon deposits

Lung cells in COPD patients show higher levels of soot-like carbon deposits

Novel self-propelled ferroptosis nanoinducer achieves deeper penetration into tumor tissues

Novel self-propelled ferroptosis nanoinducer achieves deeper penetration into tumor tissues

Study aims to demystify the immune toxicity triggered by osimertinib-ICI co-treatment

Study aims to demystify the immune toxicity triggered by osimertinib-ICI co-treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.